Syngenta released H1 16 numbers: sales were down 7% (-2% at CER) to US$7,094m, EBITDA -12% to US$1,767m, operating income -14% to US$1,351m, net income -13% to US$1,064m. Lastly, free cash flow reached US$337m vs US$-109m last year.
22 Jul 2016
Uninspiring H1 16...thank goodness there's an offer
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Uninspiring H1 16...thank goodness there's an offer
Syngenta released H1 16 numbers: sales were down 7% (-2% at CER) to US$7,094m, EBITDA -12% to US$1,767m, operating income -14% to US$1,351m, net income -13% to US$1,064m. Lastly, free cash flow reached US$337m vs US$-109m last year.